1. Home
  2. IOVA vs ASTH Comparison

IOVA vs ASTH Comparison

Compare IOVA & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

N/A

Current Price

$3.53

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Astrana Health Inc.

ASTH

Astrana Health Inc.

N/A

Current Price

$19.82

Market Cap

996.1M

ML Signal

N/A

Company Overview

Basic Information
Metric
IOVA
ASTH
Founded
2007
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
996.1M
IPO Year
2008
2015

Fundamental Metrics

Financial Performance
Metric
IOVA
ASTH
Price
$3.53
$19.82
Analyst Decision
Buy
Strong Buy
Analyst Count
12
9
Target Price
$10.45
$40.78
AVG Volume (30 Days)
9.3M
567.4K
Earning Date
05-25-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
32.28
N/A
EPS
N/A
0.33
Revenue
N/A
$519,907,752.00
Revenue This Year
$60.04
$58.46
Revenue Next Year
$58.54
$25.22
P/E Ratio
N/A
$60.48
Revenue Growth
N/A
45.90
52 Week Low
$1.64
$18.08
52 Week High
$5.64
$36.20

Technical Indicators

Market Signals
Indicator
IOVA
ASTH
Relative Strength Index (RSI) 77.86 38.64
Support Level $2.11 $18.08
Resistance Level $3.73 $23.94
Average True Range (ATR) 0.19 1.12
MACD 0.09 0.10
Stochastic Oscillator 97.56 32.71

Price Performance

Historical Comparison
IOVA
ASTH

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About ASTH Astrana Health Inc.

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

Share on Social Networks: